Difference between revisions of "PDFF Biomarker Ctte"
Jump to navigation
Jump to search
Line 8: | Line 8: | ||
==Recent Meetings/Call Summaries== | ==Recent Meetings/Call Summaries== | ||
− | *[[Media:2017_09-07_QIBA_PDFF_Biomarker_Cmte_Call_Summary-FINAL.pdf| | + | *[[Media:2017_09-07_QIBA_PDFF_Biomarker_Cmte_Call_Summary-FINAL.pdf|September 7, 2017]] |
− | *[[Media:2017_08-03_QIBA_PDFF_Biomarker_Cmte_Call_Summary-FINAL.pdf| | + | *[[Media:2017_08-03_QIBA_PDFF_Biomarker_Cmte_Call_Summary-FINAL.pdf|August 3, 2017]] |
− | *[[Media:2017_07-06_QIBA_PDFF_Biomarker_Cmte_Call_Summary-FINAL.pdf| | + | *[[Media:2017_07-06_QIBA_PDFF_Biomarker_Cmte_Call_Summary-FINAL.pdf|July 6, 2017]] |
'''''[[PDFF Biomarker Committee Call Summaries Archive]]''''' | '''''[[PDFF Biomarker Committee Call Summaries Archive]]''''' |
Revision as of 20:30, 22 November 2017
- Co-chairs: Scott Reeder, MD, PhD, Takeshi Yokoo, MD, PhD
- Secretary: Susan Weinmann
The PDFF Biomarker Committee seeks to develop a quantitative Profile for PDFF.
Recent Meetings/Call Summaries
PDFF Biomarker Committee Call Summaries Archive